{"nct_id":"NCT00089674","title":"AMG 162 in the Treatment of Bone Loss in Subjects Undergoing Androgen-Deprivation Therapy for Non-metastatic Prostate Cancer","status":"COMPLETED","status_verified_date":"2018-09","start_date":"2004-08-01","start_date_type":"ACTUAL","primary_completion_date":"2008-05-16","primary_completion_date_type":"ACTUAL","completion_date":"2010-05-11","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["AMGN"]}